Company performance
Current Price
as of Jan 06, 2025$15.48
P/E Ratio
3.07
Market Cap
$3.99B
Loading...
Description
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Metrics
Overview
- HQJersey City, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerOGN
- Price$15.48+0.26%
Trading Information
- Market cap$3.99B
- Float99.78%
- Average Daily Volume (1m)4,698,690
- Average Daily Volume (3m)3,299,888
- EPS$5.07
Company
- Revenue$6.41B
- Rev growth (1yr)4.15%
- Net income$359.00M
- Gross margin58.34%
- EBITDA margin29.01%
- EBITDA$459.00M
- EV$12.96B
- EV/Revenue2.02
- P/E3.07
- P/S0.63
- P/B8.09
Documents
SEC Filings
Earnings Calls
Factset Street Account